Latest in Pulmonary News

Thirty-Day Hospital Readmission Metric Linked to Increased Mortality for HF and Pneumonia

Physicians are at increased pressure to reduce readmissions for certain chronic diseases. A recent study found that implementation of the 30-day readmission rules has been associated with increased 30-day post-discharge mortality for those hospitalized for heart failure and pneumonia.

Post-discharge deaths have increased by 0.25% for patients hospitalized with heart failure and by 0.40% for patients with pneumonia since the implementation of the 30-day readmission rules.
There are approximately 8 million hospitalizations during the study period. Such small increases may account for a large number of deaths.

The findings, published online in JAMA, come from a retrospective cohort study that compared mortality rates among 8.3 million Medicare beneficiaries hospitalized for these common conditions before and after implementation of the Hospital Readmissions Reduction Program (HRRP). This early data should lead physicians to exercise caution in discharging patients prematurely.

Source: Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia. JAMA. 2018;320(24):2542-2552. doi:10.1001/jama.2018.19232

Add Corticosteroids to Your Arsenal for the treatment of Inpatient Community-Acquired Pneumonia.

Corticosteroids were both beneficial and cost-effective for hospitalized adults with severe CAP. Hospitalized people with non-severe CAP may also benefit from corticosteroid therapy, but with no survival advantage

In 2015, results of two randomized trials showed that systemic corticosteroids were beneficial for some hospitalized patients with community-acquired pneumonia (CAP; NEJM JW Gen Med Mar 15 2015 and JAMA 2015; 313:677; NEJM JW Gen Med Mar 1 2015 and Lancet 2015; 385:1511). Now, two new meta-analyses — one by the Cochrane Library, and one by the Infectious Diseases Society of America (IDSA) — address whether CAP patients should receive systemic corticosteroids routinely.

These meta-analyses suggest that low-dose (≈40 mg), short-course (3–7 days) systemic corticosteroids should be strongly considered for hospitalized adults with severe CAP. These results do not apply to outpatients with CAP or to inpatients with hospital-acquired pneumonia or ventilator-associated pneumonia. Several ongoing randomized trials probably will clarify steroid use further for pneumonia indications.

Source:
The Cost-effectiveness of Corticosteroids for the treatment of Community-Acquired Pneumonia
Chest. 2018 Nov 15. pii: S0012-3692(18)32727-2. doi: 10.1016/j.chest.2018.11.001.
https://www.ncbi.nlm.nih.gov/pubmed/30448195?dopt=Abstract

Home oxygen therapy for COPD: Does it matter whether the patient is hypoxemic? Evidence vs Reality

Home oxygen therapy for COPD: Does it matter whether the patient is hypoxemic? Evidence vs Reality?

Long-term oxygen therapy (LTOT) is given to improve survival time in people with COPD and severe chronic hypoxemia at rest. The efficacy of oxygen therapy for breathlessness and health-related quality of life (HRQOL) in people with COPD and mild or no hypoxemia who do not meet the criteria for LTOT has not been established. Scientific evidence for its benefits of LTOT dates back to the 1980s when two randomized controlled trials showed prolonged survival in COPD-patients undergoing LTOT for at least 15 hours/day. In contrast, the potential benefits of LTOT in non-COPD-patients has not been well researched and the recommendations for its application are primarily extrapolated from trials on COPD-patients.

Recent Cochrane analysis found that oxygen can relieve breathlessness when given during exercise to mildly hypoxaemic and non-hypoxaemic people with chronic obstructive pulmonary disease who would not otherwise qualify for home oxygen therapy. Findings show that COPD patients without severe hypoxemia undergoing oxygen therapy during exercise training over time do not achieve better exercise capacity or health-related quality of life compared with placebo.

However, LTOT has a beneficial effect on quality of life, dyspnea, and exercise capacity in patients with COPD and exertional hypoxemia.

Source:
Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006429.pub3/full

J Bras Pneumol. 2018 Sep-Oct;44(5):390-397. doi: 10.1590/S1806-37562017000000019.
Impact of adherence to long-term oxygen therapy on patients with COPD and exertional hypoxemia followed for one year.
https://www.ncbi.nlm.nih.gov/pubmed/30517340

Latest in Pulmonary Research

  1. Yue, M, Gaietto, K, Han, YY, Rosser, FJ, Xu, Z, Qoyawayma, C et al.. Transcriptomic Profiles in Nasal Epithelium and Asthma Endotypes in Youth. JAMA. 2025; :. doi: 10.1001/jama.2024.22684. PubMed PMID:39745770 .
  2. Gomez, J, Nino, G. Uncovering Transcriptional Endotypes in Pediatric Asthma-A New Lens on Biomarker-Based Clinical Stratification. JAMA. 2025; :. doi: 10.1001/jama.2024.26977. PubMed PMID:39745764 .
  3. Shin, KWD, Atalay, MV, Cetin-Atalay, R, O'Leary, EM, Glass, ME, Houpy Szafran, JC et al.. mTOR Signaling Regulates Multiple Metabolic Pathways in Human Lung Fibroblasts After TGF-β and in Pulmonary Fibrosis. Am J Physiol Lung Cell Mol Physiol. 2025; :. doi: 10.1152/ajplung.00189.2024. PubMed PMID:39745695 .
  4. Kemme, FM, van den Berg, EL, Meij-de Vries, A, Gigengack, RK, Cuijpers, MD, van Baar, ME et al.. Trends and epidemiology of children treated in specialized burn centers in the Netherlands between 2009 and 2022. Eur J Pediatr. 2025;184 (1):114. doi: 10.1007/s00431-024-05923-7. PubMed PMID:39745598 .
  5. Wu, J, Li, L, Xu, W, Xia, X, Wu, Y. Circular RNAs in the pathogenesis of SARS-CoV-2: potential diagnostic biomarkers and therapeutic targets. Funct Integr Genomics. 2025;25 (1):4. doi: 10.1007/s10142-024-01509-6. PubMed PMID:39745517 .
  6. Haselswerdt, J, Ressel, K, Harcourt, E, Gable, S, Quinn, K. Provider capacity during Medicaid expansion and a public health emergency. Am J Manag Care. 2024;30 (12):e364-e369. doi: 10.37765/ajmc.2024.89645. PubMed PMID:39745503 .
  7. Brasier, AR. Interactions between epithelial mesenchymal plasticity, barrier dysfunction and innate immune pathways shape the genesis of allergic airway disease. Expert Rev Respir Med. 2025; :. doi: 10.1080/17476348.2024.2449079. PubMed PMID:39745473 .
  8. Al-Iede, M, Alfaouri, K, Manzlgi, D, Nazzal, L, Awaisheh, T, Alsharif, O et al.. Asthma Control, Its Related Factors, and Impact on Quality of Life Among Pediatric Patients at a Tertiary Center in Jordan: A Cross-Sectional Study. J Asthma. 2025; :1-12. doi: 10.1080/02770903.2024.2449236. PubMed PMID:39745466 .
  9. Chen, Y, Li, W, Wang, L, Wang, B, Suo, J. Novel inhibition of Staphylococcus aureus sortase A by plantamajoside: implications for controlling multidrug-resistant infections. Appl Environ Microbiol. 2024; :e0180424. doi: 10.1128/aem.01804-24. PubMed PMID:39745463 .
  10. Sanchez, GJ, Cuypers, L, Laenen, L, Májek, P, Lagrou, K, Desmet, S et al.. Prediction of antimicrobial susceptibility of pneumococci based on whole-genome sequencing data: a direct comparison of two genomic tools to conventional antimicrobial susceptibility testing. J Clin Microbiol. 2024; :e0107924. doi: 10.1128/jcm.01079-24. PubMed PMID:39745445 .
  11. Magossi, G, Gzyl, KE, Holman, DB, Nagaraja, TG, Amachawadi, R, Amat, S et al.. Genomic and metabolic characterization of Trueperella pyogenes isolated from domestic and wild animals. Appl Environ Microbiol. 2024; :e0172524. doi: 10.1128/aem.01725-24. PubMed PMID:39745423 .
  12. Bedolla-Pulido, TI, Morales-Romero, J, Pulido-Guillén, NA, De Alba-Márquez, ME, Robles-Figueroa, M, Bedolla-Barajas, M et al.. Rhinitis or asthma among adults as associated factors with symptoms of depression. Eur Ann Allergy Clin Immunol. 2025; :. doi: 10.23822/EurAnnACI.1764-1489.382. PubMed PMID:39745419 .
  13. Kottom, TJ, Carmona, EM, Schaefbauer, K, Stelzig, KE, Pellegrino, MR, Bindzus, M et al.. The importance of Fcγ and C-type lectin receptors in host immune responses during Pneumocystis pneumonia. Infect Immun. 2024; :e0027624. doi: 10.1128/iai.00276-24. PubMed PMID:39745390 .
  14. Claeys, KC, Simner, PJ, Tekle, T, Harris, AD, Jacobs, E, Cosgrove, SE et al.. How accurate is ceftriaxone at predicting susceptibility of enterobacterales isolates to oral higher-generation cephalosporins?. Antimicrob Agents Chemother. 2024; :e0138724. doi: 10.1128/aac.01387-24. PubMed PMID:39745384 .
  15. Torres-Mejia, E, Weng, S, Whittaker, CA, Nguyen, KB, Duong, E, Yim, L et al.. Lung cancer-intrinsic SOX2 expression mediates resistance to checkpoint blockade therapy by inducing Treg cell-dependent CD8+ T-cell exclusion. Cancer Immunol Res. 2025; :. doi: 10.1158/2326-6066.CIR-24-0184. PubMed PMID:39745382 .
  16. Johannson, KA, Adegunsoye, A, Behr, J, Cottin, V, Glanville, AR, Glassberg, MK et al.. Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease. Am J Respir Crit Care Med. 2025; :. doi: 10.1164/rccm.202409-1730PP. PubMed PMID:39745380 .
  17. Huang, T, Che, S, Lv, Z, Hao, D, Wang, R, Yi, Q et al.. mRNA-LNP vaccines combined with tPA signal sequence elicit strong protective immunity against Klebsiella pneumoniae. mSphere. 2024; :e0077524. doi: 10.1128/msphere.00775-24. PubMed PMID:39745376 .
  18. Zhao, X, Zhang, Y, Ju, M, Yang, Y, Liu, H, Qin, X et al.. RamA upregulates the ATP-binding cassette transporter mlaFEDCB to mediate resistance to tetracycline-class antibiotics and the stability of membranes in Klebsiella pneumoniae. Microbiol Spectr. 2024; :e0172824. doi: 10.1128/spectrum.01728-24. PubMed PMID:39745369 .
  19. Khalil, KA, Alsultan, M, Daher, NA. Microbial profile and antimicrobial resistance patterns in ventilator-associated pneumonia (VAP): A cross-sectional study from Syria. J Postgrad Med. 2025; :. doi: 10.4103/jpgm.jpgm_565_24. PubMed PMID:39745288 .
  20. Schuler, M. Facts and hopes in neoadjuvant immunotherapy combinations in resectable non-small-cell lung cancer. Clin Cancer Res. 2025; :. doi: 10.1158/1078-0432.CCR-24-1441. PubMed PMID:39745266 .
  21. Kumbasar, U, Köksal, D, Yilmaz, Y, Uysal, S. Lung cancer associated with cystic airspaces: A contemporary review. Tuberk Toraks. 2024;72 (4):307-315. doi: 10.5578/tt.202404980. PubMed PMID:39745231 .
  22. Öztürk, G, Haskoloğlu, Ş, Olgun, EG, Sevinç, S, Islamoğlu, C, Zirek, F et al.. Two different diseases in two adolescent girls with the same clinic: Allergic bronchopulmonary aspergillosis. Tuberk Toraks. 2024;72 (4):300-306. doi: 10.5578/tt.202404964. PubMed PMID:39745230 .
  23. Yakar, Hİ, Kiziloğlu, HA. An important radiological clue in idiopathic pulmonary fibrosis: Diffuse pulmonary ossification. Tuberk Toraks. 2024;72 (4):288-294. doi: 10.5578/tt.202404984. PubMed PMID:39745228 .
  24. Sahutoğlu, E, Kabak, M, Çil, B, Atay, K, Peker, A, Güler, Ş et al.. Radiologic severity index can be used to predict mortality risk in patients with COVID-19. Tuberk Toraks. 2024;72 (4):280-287. doi: 10.5578/tt.202404994. PubMed PMID:39745227 .
  25. Şimşek, ŞM, Kizilirmak, D, Havlucu, Y. The effectiveness of telemedicine methods in the follow-up of asthma in the COVID-19 pandemic process. Tuberk Toraks. 2024;72 (4):268-279. doi: 10.5578/tt.202404935. PubMed PMID:39745226 .
Search PubMed

Search Terms: Asthma, COPD, Lung Cancer, Pneumonia, Pulmonary Fibrosis

Back to top